State’s first-ever decentralized tech conference to showcase Arizona’s technology leadership and bring together top innovators, founders, and investorsContinue reading
Author Archive: AZBio
Fiscal year 2025, the University of Arizona breaks record (again) for impactful inventions
Faculty and student engagement in innovation and commercialization continues to grow.
Arizona Commerce Authority Accepting Applications For 2025 Arizona Innovation Challenge
The Fall 2025 cohort will focus on SaaS startups
“With the prominent growth of the software market globally and in Arizona, we’re excited to support SaaS-focused startups through this year’s Arizona Innovation Challenge,” said Sandra Watson, President and CEO of the Arizona Commerce Authority. “We’re grateful to our Arizona venture capitalist partners for their collaboration and look forward to seeing the exciting startups in this year’s competition.”
AdvaMed is Celebrating 50 Years of Medtech Milestones
As we celebrate the 50th anniversary of AdvaMed, the Medtech Association, we recognize the critical role the medtech industry has played – and always will play – in transforming people’s lives. As the current Administration launches it’s “Make America Healthy Again” initiative, it’s important that we remember that the medtech industry has been making America healthy again since its inception. The story of medtech is the most powerful story in health care and it really is a story as old as toolmaking itself. It is the story of getting people back to good health. Back to “normal.” Back to playing with their grandchildren. Back to moving, walking, and even seeing again. Back to life. Continue reading
2025 Award for Leadership in Personalized Medicine to be Awarded to George Poste, DVM, PhD
PMC, the Personalized Medicine Coalition, announced that George Poste, DVM, PhD, Regents Professor and Del E. Webb Chair in Health Innovation and Chief Scientist, Complex Adaptive Systems Initiative at Arizona State University, will receive the 2025 Award for Leadership in Personalized Medicine at this year’s Personalized Medicine Conference, to be held November 13–14 at the Ritz Carlton, Laguna Niguel, in Dana Point, California. This award recognizes Dr. Poste’s substantial multi-decade contributions to the advancement of personalized medicine and his enduring impact on science, technology, and policy.Continue reading
Marvin Slepian recognized with Distinguished Faculty Award
Marvin J. Slepian, MD, JD, a Regents Professor of medicine, radiology and imaging sciences and surgery at the University of Arizona College of Medicine – Tucson and of biomedical engineering at the U of A College of Engineering, received this year’s University Distinguished Innovation and Entrepreneurship Award. Continue reading
NIH researchers develop AI agent that improves accuracy of gene set analysis by leveraging expert-curated databases
Researchers at the National Institutes of Health (NIH) have developed an artificial intelligence (AI) agent powered by a large language model (LLM) that creates more accurate and informative descriptions of biological processes and their functions in gene set analysis than current systems.Continue reading
Study reveals a novel immune-based therapy that may be effective in hard-to-treat lung cancers
Findings suggest that the patients themselves produce molecules that could reawaken their immune system to battle lung cancerContinue reading
Celebrating Suzanne Pfister’s Legacy
Suzanne Pfister, an extraordinary leader and public servant whose tenure as Vitalyst Health Foundation’s President and CEO transformed the organization and inspired paradigm-shifting change across Arizona’s health landscape.
Continue reading
Stanford faculty member George Tidmarsh, M.D., Ph.D. named Director of Center for Drug Evaluation and Research
The U.S. Food and Drug Administration today announced the appointment of George Francis Tidmarsh, M.D., Ph.D., as Director of the Center for Drug Evaluation and Research (CDER). In this role, Dr. Tidmarsh will lead the FDA’s efforts to ensure safe, effective, and high-quality drugs are available to the American people.Continue reading